- Patent Title: Anti-Blys antibody formulations and methods of treatment using them
-
Application No.: US15311223Application Date: 2015-05-15
-
Publication No.: US10556009B2Publication Date: 2020-02-11
- Inventor: Angela Blake-Haskins , Tristan Marshall , Melissa D. Perkins , Kristin O'Berry
- Applicant: GlaxoSmithKline Intellectual Property Management Limited
- Applicant Address: GB
- Assignee: GlaxoSmithKline Intellectual Property Management Limited
- Current Assignee: GlaxoSmithKline Intellectual Property Management Limited
- Current Assignee Address: GB
- Agent Hao Yin
- International Application: PCT/IB2015/053602 WO 20150515
- International Announcement: WO2015/173782 WO 20151119
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; C07K16/24 ; A61K39/00
Abstract:
The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent.
Public/Granted literature
- US20170095555A1 ANTIBODY FORMULATION Public/Granted day:2017-04-06
Information query
